Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Sitemap: |
Title | Medicine from Biologics Experts | Amgen |
Description | Leaving With over four decades of experience, Amgen is an end-to-end biologics expert, bringing innovation to the research and development of innovative |
Keywords | biosimilar, biosimilars, biosimilar medicines, Amgen biosimilars, innovator biologics |
WebSite | amgenbiosimilars.com |
Host IP | 54.148.237.9 |
Location | United States |
Site | Rank |
US$8,076,773
Last updated: 2023-04-30 22:09:14
amgenbiosimilars.com has Semrush global rank of 1,310,462. amgenbiosimilars.com has an estimated worth of US$ 8,076,773, based on its estimated Ads revenue. amgenbiosimilars.com receives approximately 931,936 unique visitors each day. Its web server is located in United States, with IP address 54.148.237.9. According to SiteAdvisor, amgenbiosimilars.com is safe to visit. |
Purchase/Sale Value | US$8,076,773 |
Daily Ads Revenue | US$7,456 |
Monthly Ads Revenue | US$223,665 |
Yearly Ads Revenue | US$2,683,974 |
Daily Unique Visitors | 62,130 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
amgenbiosimilars.com. | A | 299 | IP: 54.148.237.9 |
amgenbiosimilars.com. | A | 299 | IP: 54.201.250.38 |
amgenbiosimilars.com. | NS | 86400 | NS Record: ns-974.awsdns-57.net. |
amgenbiosimilars.com. | NS | 86400 | NS Record: ns-1142.awsdns-14.org. |
amgenbiosimilars.com. | NS | 86400 | NS Record: ns-1756.awsdns-27.co.uk. |
amgenbiosimilars.com. | NS | 86400 | NS Record: ns-195.awsdns-24.com. |
amgenbiosimilars.com. | TXT | 300 | TXT Record: google-site-verification=LOAY9TLcXjLI4NOcppIMpBwYDUDiteIO9VeBj7NIN3s |
Medicine from Biologics Experts | Amgen Biosimilars CLEAR X Heritage Deep Experience Worldwide Biologics Leader Therapeutic Area Heritage Expertise Highly Specialized Knowledge Discovery Manufacturing Clinical Testing Quality Assurance Therapeutic Area Expertise Commitment Biologics Development Significant Investments Impacts of Biosimilars Therapeutic Area Commitment 2022 Biosimilar Trends Report Support Solution-Oriented Services Value Our Products FDA-Approved Products Our Pipeline Clinical Trials Media Media Releases Amgen in the News Amgen US Biosimilars Policy Positions Biosimilars Education About Biosimilars Prescribing Biosimilars Biosimilars Development and Regulatory Pathways Biosimilars Resources Biosimilars Glossary Menu Description Experience that can’t be replicated Amgen Biosimilars are backed by our four decades of experience in the research, development, manufacturing, and supply of innovator biologics. Discover resources for patients. Learn more Explore our |
HTTP/1.1 403 Forbidden Server: awselb/2.0 Date: Sat, 23 Oct 2021 15:57:21 GMT Content-Type: text/html Content-Length: 118 Connection: keep-alive |
Domain Name: AMGENBIOSIMILARS.COM Registry Domain ID: 1757524602_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2020-10-05T09:14:46Z Creation Date: 2012-11-06T20:05:34Z Registry Expiry Date: 2022-11-06T20:05:34Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1142.AWSDNS-14.ORG Name Server: NS-1756.AWSDNS-27.CO.UK Name Server: NS-195.AWSDNS-24.COM Name Server: NS-974.AWSDNS-57.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T02:08:46Z <<< |